Drug intelligence / Profile preview

Salivart

Development stage
Phase 1
Lead developer
Gebauer
Modality
Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Small Molecules, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Administration
Topical
01

Overview

Salivart is a brand-name synthetic saliva substitute designed to provide temporary relief from xerostomia (dry mouth) and associated oral discomfort. It is formulated to mimic the chemical and physical properties of natural human saliva, providing essential lubrication and moisture to the oral mucosa. The product is commonly used by patients experiencing dry mouth due to conditions such as Sjögren's syndrome, medication side effects, chemotherapy, or head and neck radiation therapy. Salivart typically contains a combination of electrolytes (including sodium, potassium, calcium, and magnesium salts) and a thickening agent, such as carboxymethylcellulose, to achieve a viscosity similar to natural saliva. It is applied topically to the mouth and throat and is not intended for systemic absorption.

Brand names
Salivart
Other names
Saliva substituteSynthetic saliva

Beyond the preview

Go deeper on Salivart.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Salivart.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call